In nasopharyngeal carcinomas (NPC), similar to the findings in hepatic carcinomas, the inhibition of Atoh8 was shown to enhance the malignant phenotype, whereas its transgenic expression was shown to reverse the phenotype. Here, ATOH8 is linked to nasopharyngeal carcinoma.